{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:33:51Z","timestamp":1759538031437,"version":"build-2065373602"},"reference-count":5,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"unspecified","delay-in-days":26,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2023,1,26]]},"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1136\/jitc-2023-006730","type":"journal-article","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T08:56:10Z","timestamp":1677488170000},"page":"e006730","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Better understanding of ICI-induced cholangitis for better management"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5697-286X","authenticated-orcid":false,"given":"Lucy","family":"Meunier","sequence":"first","affiliation":[{"name":"Hepatology, CHU Montpellier, Montpellier, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Maria","sequence":"additional","affiliation":[{"name":"Internal Medicine & Immuno-Oncology (MedI2O), CHU Montpellier, Montpellier, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,2,27]]},"reference":[{"key":"2025100303123158000_11.2.e006730.1","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005635","article-title":"Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events","volume":"10","author":"Coukos","year":"2022","journal-title":"J Immunother Cancer"},{"key":"2025100303123158000_11.2.e006730.2","unstructured":"Hountondji L , Matos CFD , Leboss\u00e9 F , et al . n.d. CHeckpoint inhibitor-induced liver injury (CHILI): a multicenter cohort of 117 patients. Submitted, in Revision"},{"key":"2025100303123158000_11.2.e006730.3","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41379-020-00653-1","article-title":"Liver biopsy findings in patients on immune checkpoint inhibitors","volume":"34","author":"Cohen","year":"2021","journal-title":"Mod Pathol"},{"issue":"1S Suppl 1","key":"2025100303123158000_11.2.e006730.4","doi-asserted-by":"crossref","first-page":"e858","DOI":"10.1097\/MEG.0000000000002280","article-title":"Immune-Related cholangitis induced by immune checkpoint inhibitors: a systematic review of clinical features and management","volume":"33","author":"Pi","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2025100303123158000_11.2.e006730.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.02.014"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2023-006730","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T10:12:41Z","timestamp":1759486361000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2023-006730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":5,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2,27]]},"published-print":{"date-parts":[[2023,2]]}},"alternative-id":["10.1136\/jitc-2023-006730"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2023-006730","relation":{},"ISSN":["2051-1426"],"issn-type":[{"type":"electronic","value":"2051-1426"}],"subject":[],"published":{"date-parts":[[2023,2]]}}}